Industries > Pharma > Global Growth Hormone Drugs Market Forecast to 2027

Global Growth Hormone Drugs Market Forecast to 2027

Somatropin and Mecasermin Based Drugs, Innovator Generics and Biosimilars, Norditropin, Genotropin, Humatrope, Saizen, Nutropin, Omnitrope, Zomacton, R&D and Leading Companies

PUBLISHED: 29 November 2017
PAGES: 184
PRODUCT CODE: PHA0261

Clear
WOOCS 2.2.1
SKU: PHA0261 Categories: , ,

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 184-page report you will receive 78 tables and 106 figures– all unavailable elsewhere.

The 184-page report provides clear detailed insight into the Growth Hormone Drugs Market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

The Global Growth Hormone Drugs market was estimated at $3.8 billion in 2016 and is expected to grow at a CAGR of 3.6% during 2017-2027. Somatropin based drugs led the market with 98.9% of the market share.

Read on to discover how this definitive report can transform your own research and save you time.

The new market assessment benefits research, analysis and planning in seven main ways:
• World growth hormone drugs market revenue to 2027 – discover that industry’s overall sales potential
• Two product classes’ revenues to 2027 – investigate categories at world level, finding the most lucrative and promising therapy classes
• Seven leading drugs’ revenues to 2027 – find sales predictions for top and emerging products, seeing how agents compete and succeed
• 7 national markets in the Americas, Europe and Asia covered, with forecasts to 2027 – discover the best countries for trade expansion
• Activities of established, rising and emerging companies – hear about firms’ products, capabilities, advances, collaborations and outlooks
• R&D for growth hormone medicines – investigate progress in that industry, exploring technological, clinical and commercial opportunities
• Analysis of what stimulates and restrains that industry and market – assess challenges, strengths, competition and opportunities, helping you succeed.

There you explore business intelligence with research, opinions and predictions found only in that work.

Trying our investigation now lets you discover trends, opportunities and prospects
For growth hormone drugs, our report shows you data, trends, opportunities and multilevel sales forecasts. So, avoid missing out. Instead please get that new analysis here now.

Report highlights

• 184-pages, 78 tables and 106 figures

• Growth Hormone Drugs Market Forecast from 2017 to 2027

• This report also breaks down the revenue forecast for the main submarkets:
• Innovator Generics
• Biosimilars
• Mecasermin based drugs
• Somatropin based drugs

Analysis of the Innovator Generics drugs market. Revenue forecasts to 2027 are provided for the following drugs:
• Norditropin
• Genotropin
• Humatrope
• Saizen
• Nutropin

Analysis of the Biosimilar drugs market. Revenue forecasts to 2027 are provided for the following drugs:
• Omnitrope
• Zomactan. Tev-tropin/ Growject

Analysis of key players in Growth Hormone Drugs
• Merck KGaA
• Roche
• Novartis
• Novo Nordisk
• Eli Lilly and Co.
• Pfizer Inc.

Regional Growth Hormone Drugs market forecasts from 2017-2027
• US forecast 2017-2027,
• Japan forecast 2017-2027
• Germany forecast 2017-2027
• UK forecast 2017-2027
• France forecast 2017-2027
• Italy forecast 2017-2027
• Spain forecast 2017-2027

Global Growth Hormone Drugs Market Forecast to 2027

Key questions answered
• How is the Growth Hormone Drugs market evolving?
• What is driving and restraining Growth Hormone Drugs market dynamics?
• How will each Growth Hormone Drugs submarket market grow over the forecast period and how much Sales will these submarkets account for in 2026?
• How will market shares of each Growth Hormone Drugs submarket develop from 2017-2027?
• Which individual technologies will prevail and how will these shifts be responded to?
• Which Growth Hormone Drugs submarket will be the main driver of the overall market from 2017-2027?
• How will political and regulatory factors influence regional Growth Hormone Drugs markets and submarkets?
• Will leading national Growth Hormone Drugs markets broadly follow macroeconomic dynamics, or will individual country sectors outperform the rest of the economy?
• How will market shares of the national markets change by 2026 and which nation will lead the market in 2026?
• Who are the leading players and what are their prospects over the forecast period?
• How will the sector evolve as alliances form during the period between 2017 and 2027?

• Target audience
• Leading Growth Hormone Drug Compaies
• Suppliers
• Contractors
• Technologists
• R&D staff
• Consultants
• Analysts
• CEO’s
• CIO’s
• COO’s
• Business development managers
• Investors
• Governments
• Agencies
• Industry organisations
• Banks

With our study you see how that market can develop and perform, benefiting your reputation for insight and authority.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Growth Hormone Drugs Market Forecast to 2027


Download sample pages

Complete the form below to download your free sample pages for Global Growth Hormone Drugs Market Forecast to 2027


Latest Pharma news

Visiongain Publishes Dermatological Drugs Market Report 2021-2031

The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.

18 January 2021

READ

Visiongain Publishes Antigen Skin Test Market Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing health concerns among population and growing incidences of fungal & bacterial infection are some of the factors driving the growth of Antigen Skin Test market.

12 January 2021

READ

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021

Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.

11 January 2021

READ

Visiongain Publishes Anti-Infective Vaccines Market Report Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market.

11 January 2021

READ

Categories

Category